Home/Filings/4/0001127602-22-003846
4//SEC Filing

Pletcher Brett A 4

Accession 0001127602-22-003846

CIK 0000882095other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:24 PM ET

Size

8.1 KB

Accession

0001127602-22-003846

Insider Transaction Report

Form 4
Period: 2022-02-06
Pletcher Brett A
EVP, Gen Counsel & Corp Sec
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-06+2,72735,303 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-02-062,72723,024 total
    Common Stock (2,727 underlying)
  • Tax Payment

    Common Stock

    2022-02-06$63.90/sh1,036$66,20034,267 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

Issuer

GILEAD SCIENCES INC

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001739307

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:24 PM ET
Size
8.1 KB